OWC Pharmaceutical Research Corp (OWCP)

[BruceLake]

In case anybody needs to be reminded, individual investors kept the company afloat through the sale of restricted shares in early 2017. Shareholders have every right to ask questions before they are asked to part with their money. I could write a book, a tragic comedy, on the many questions and BS answers that I received from the company's management and their so-called advisers.

If the company had been forthright, delivered on their promises, and not lied outright to its shareholders, we wouldn't be having this conversation today. If OWC had been legitimate, and if they had done a better job of communicating with its shareholders, they would not have had too much difficulty raising more funds. SEC filings, and news releases is not considered to be communication. Especially when more often than not they were riddled with mistakes and inconsistencies, and resulted in more questions than answers.

The Chairman, aka Mr. Massive Value, did not earn the trust of shareholders that would allow him to be so arrogant as to not feel the need to address questions directly. After all why did he attend the various conferences begging for money, if he wasn't planning on answering any questions?

In one of the several conversations that I had with Yossi Dagan, their previous CFO, he made the comment that dealing with small individual investors proved to be time-consuming, and that was the reason why they were looking for an institutional investor. Enter DGF > Toxicity > Dilution > Demise of the company and shareholder value.

On another issue, according to the latest filing:

As of May 17, 2019, we had issued 46,865,656 shares of our common stock to the Investor upon conversion of, and in payment of dividends on, 67 Series A Preferred Shares, of which 41,690,716 shares have been previously resold.

Means that DGF may not necessarily have as many shares as you might think to influence the vote one way or the other. I'm still voting NO!!!